Display Settings:

Format

Send to:

Choose Destination
    Rev Med Suisse. 2009 Jan 14;5(186):118-23.

    [Gene therapy for hereditary eye diseases: where are we?].

    [Article in French]

    Source

    Unité de phénotypage et thérapie moléculaire, Hôpital ophtalmique universitaire Jules-Gonin, 1004 Lausanne. h.tran@ucl.ac.uk

    Abstract

    Recently, preliminary results of three clinical gene therapy trials for early onset retinitis pigmentosa--Leber congenital amaurosis--suggested that treating this degenerative retinal disease by gene transfection can be safe and efficient to restore a visual function. The definitive validation of this therapeutic approach depends on the long-term results. The forthcoming availability of gene therapy in ophthalmology prompts the implementation: of 1) recruitment, 2) phenotyping and genotyping of affected patients, 3) and creation of a hereditary retinopathy registry.

    PMID:
    19238930
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk